iSpecimen Soars 81% Amid Recent News

iSpecimen Inc. today announced it has been selected to support new research related to COVID-19. This project aims to identify the transmissibility, variants, and testing validity of COVID-19 in various populations. ISPC stock soars 81% today, jumping to the price of $18.52. iSpecimen is pleased to support new research on COVID-19, which is seeking to improve the diagnostic accuracy and utility of the drug. Through its extensive experience in the biospecimen industry, iSpecimen is well-suited to support these types of projects. The Company’s work with COVID-19 started right after the rash. It provided the CDC with 600 serum samples and 100 negative samples, mostly remnants of lab tests.

GettyImages 1209679043Custom COVID-19 collections are also available from various federal offices and private organizations. A project carried out by iSpecimen involves enlisting the help of household members and other individuals who may be affected by COVID-19 testing. These individuals can then schedule a follow-up test if they develop COVID-19 symptoms after being subjected to the test. The patients with positive COVID-19 give their blood samples to the company.  Each sample type is collected across a variety of geographic regions and ethnicities. In some cases, variants are identified by carefully sequencing the samples to identify potential variants.

Anthony Gonzales

Biotech, Tech, and Crypto reporter Anthony Gonzales brings 3 years of experience in helping grassroots, mid-sized organizations and large institutions strengthen their management and resource generating capacities and effectively plan for the future. He is also a mentor and professional advisor to artists working in all disciplines. He is the gold medalist from St. Marco University of Science and Technology in the Bachelors of Financial Management as well.

Anthony Gonzales has 1700 posts and counting. See all posts by Anthony Gonzales